Tokyo, March 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060951) titled 'Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)' on March 17.
Study Type:
Observational
Primary Sponsor:
Institute - Sendai City Medical Center Sendai Open Hospital
Condition:
Condition - Patients undergoing colonoscopy (for screening or diagnostic purposes)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - 1. To calculate the clinical equipotent dose ratio of RMZ to PRO in the same patients under opioid-free conditions.
2. To v...